Skip to content

Bio-Techne TECH Diagnostics — Goodwill

Discontinued — last reported Q4 '18

Similar metrics at other companies

Agilent Technologies logo
ADiagnostics and Genomics — Goodwill
$2.64B+24.1%
Labcorp Holdings logo
LHDiagnostics — Goodwill
$5.61B
Revvity logo
RVTYDiagnostics — Goodwill, Acquisition
$0
Agilent Technologies logo
ADiagnosticsandgenomicssolutions — Goodwill Transfers
$11.25M
Revvity logo
RVTYDiagnostics — Goodwill
$1.86B-4.0%
Bio-Rad Laboratories logo
BIO.BClinical Diagnostics — Goodwill

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$9.07B-11.8%
Enterprise value$9.15B-13.6%
P/E60.6×+13.6×
P/S7.5×-1.0×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Bio-Techne’s 10-K, filed August 27, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does diagnostics — goodwill mean?
The total value of intangible assets like brand and market position recorded from past acquisitions in the diagnostics segment.
How do you interpret diagnostics — goodwill?
High levels relative to segment assets may indicate potential for future impairment charges if the segment underperforms.
How does diagnostics — goodwill compare across companies?
Goodwill levels vary significantly based on the M&A history of the company compared to organic growth-focused peers.